Open Access · CC BY-NC 4.0
What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?
Archives of Breast Cancer · 2018
DOI: 10.32768/abc.201854148-149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Breast Cancer, 2018. Verfasst von Elmira Ebrahimi und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
N/A
Zitieren
APA
Ebrahimi, E., & Shirkoohi, R. (2018). What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?. Archives of Breast Cancer. https://doi.org/10.32768/abc.201854148-149
Vancouver
Ebrahimi E, Shirkoohi R. What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?. Archives of Breast Cancer. 2018. doi:10.32768/abc.201854148-149
BibTeX
@article{Ebrahimi2018,
author = {Ebrahimi, Elmira and Shirkoohi, Reza},
title = {What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?},
journal = {Archives of Breast Cancer},
year = {2018},
doi = {10.32768/abc.201854148-149}
}
EUVIMED